Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects

Journal of Headache and Pain

Volumn 10, Issue 2, 2009, Pages 115-120

  Gupta, Ravi ^a   Kumar, Vivek ^a   Luthra, Kalpana ^b   Banerjee, Basudeb ^a   Bhatia, Manjeet Singh ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

APOE polymorphism; Migraine; Tension type headache

Indexed keywords

APOLIPOPROTEIN E; GENOMIC DNA;

ADULT; ARTICLE; BLOOD STORAGE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; TENSION HEADACHE; VENOUS BLOOD;

ADULT; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIGRAINE DISORDERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TENSION-TYPE HEADACHE;

EID: 62749126037     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-008-0094-y     Document Type: Article

References (42)

1. Olesen J, Thomsen LL, Lassen LH et al (1995) The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 15:99-100
2. Olesen J, Iversen HK, Thomsen LL (1993) Nitric oxide supersensitivity: A possible molecular mechanism of migraine pain. Neuroreport 15:94-100
3. Tassorrelli C, Joseph SA (1995) Systemic nitroglycerin induces Fos immunoreactivity in brain-stem and forebrain structures of the rat. Brain Res 682:167-181
4. Hoskin KL, Bulmer DCE, Goadsby PJ (1999) Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. Neurosci Lett 266:173-176
5. Ashina M (2004) Neurobiology of chronic tension-type headache. Cephalalgia 24:161-172
6. Czapiga M, Colton CA (2003) Microglial function in human APOE3 and APOE4 transgenic mice: Altered arginine transport. J Neuroimmunol 134:44-51
7. Colton CA, Brown CM, Cook D et al (2002) APOE and the regulation of microglial nitric oxide production: A link between genetic risk and oxidative stress. Neurobiol Aging 23:777-785
8. Brown CM, Wright E, Colton CA et al (2002) Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic Biol Med 32:1071-1075
9. Guo L, LaDu MJ, Van Eldik LJ (2004) A dual role for apolipoprotein e in neuroinflammation: Anti- and pro-inflammatory activity. J Mol Neurosci 23:205-212
10. Perini F, D'Andrea G, Galloni E et al (2005) Plasma cytokine levels in migraine and controls. Headache 45:926-931
11. Tsoi LM, Wong KY, Liu YM et al (2007) Apoprotein E isoform-dependent expression and secretion of pro-inflammatory cytokines TNF-alpha and IL-6 in macrophages. Arch Biochem Biophys 460:33-40
12. Tziakas DN, Chalikias GK, Antonoglou CO et al (2006) Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease. J Am Coll Cardiol 48:2471-2481
13. Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders. Cephalalgia; 24(Suppl 1):1-151
14. Pantelidis P, Lambert-Hammill M, Wierzbicki AS (2003) Simple sequence-specific primer-PCR method to identify the three main apolipoprotein E haplotypes. Clin Chem 49:1945-1948
15. Rainero I, Grimaldi LM, Salani G et al (2002) Apolipoprotein E gene polymorphisms in patients with migraine. Neurosci Lett 317:111-113
16. Tamura Y, Kataoka Y, Cui Y et al (2004) Cellular proliferation in the cerebral cortex following neural excitation in rats. Neurosci Res 50:129-133
17. Fiebich BL, Lieb K, Engels S et al (2002) Inhibition of LPS-induced p42/ 44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J Neuroimmunol 132:18-24
18. Gergont A, Kaciński M, Kwinta P (2005) Proinflammatory cytokines in children with idiopathic headache. Przegl Lek 62:1269-1275
19. Gergont A, Kaciński M (2005) Blood interleukin-6 level in children with idiopathic headaches. Neurol Neurochir Pol 39(4 Suppl 1):S1-S8
20. Maezawa I, Nivison M, Montine KS et al (2006) Neurotoxicity from innate immune response is greatest with targeted replacement of E4 gene of apolipoprotein E gene and is mediated by microglial p38MAPK. FASEB J 20:797-799
21. Chen S, Averett NT, Manelli A et al (2005) Isoform-specific effects of apolipoprotein E on secretion of inflammatory mediators in adult rat microglia. J Alzheimers Dis 7:25-35
22. Lynch JR, Tang W, Wang H et al (2003) APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 278:48529-48533
23. Grünenfelder J, Umbehr M, Plass A (2004) Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass. J Thorac Cardiovasc Surg 128:92-97
24. Alehan FK (2002) Value of neuroimaging in the evaluation of neurologically normal children with recurrent headache. J Child Neurol 17:807-809
25. Johnson MP, Lea RA, Colson NJ et al (2005) A population genomics overview of the neuronal nitric oxide synthase (nNOS) gene and its relationship to migraine susceptibility. Cell Mol Biol (Noisy-le-grand) 51:285-292
26. Lea RA, Curtain RP, Shepherd AG et al (2001) No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. Am J Med Genet 105:110-113
27. McCallum LK, Fernandez F, Quinlan S et al (2007) Association study of a functional variant in intron 8 of the dopamine transporter gene and migraine susceptibility. Eur J Neurol 14:706-707
28. Rainero I, Salani G, Valfrè W et al (2003) Absence of linkage between the interleukin-6 gene (-174 G/C) polymorphism and migraine. Neurosci Lett 343:155-158
29. Lance JW, Goadsby PJ (2005) Mechanism and management of headache. Elsevier, Philadelphia
30. Luthra K, Bharghav B, Chabbra S et al (2002) Apolipoprotein E polymorphism in northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins. Mol Cell Biochem 232:97-102
31. Chandak GR, Sridevi MU, Vas CJ et al (2002) Apolipoprotein E and presenilin-1 allelic variation and Alzheimer's disease in India. Hum Biol 74:683-693
32. Kurth T (2007) Migraine and ischemic vascular events. Cephalagia 27(8):965-975
33. Luthra K, Prasad K, Kumar P et al (2002) Apolipoprotein E gene polymorphism in cerebrovascular disease: A case-control study. Clin Genet 62:39-44
34. Saidi S, Slamia LB, Ammou SB et al (2007) Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels. J Stroke Cerebrovasc Dis 16:160-166
35. Chen K, Reiman EM, Alexander GE et al (2007) Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. Am J Psychiatry 164:916-921
36. Lemaétre H, Crivello F, Dufouil C et al (2005) No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 24:1205-1213
37. Mori E, Lee K, Yasuda M et al (2002) Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. Ann Neurol 51:209-214
38. Cox DG, Kraft P (2006) Quantification of the power of Hardy-Weinberg equilibrium testing to detect genotyping error. Hum Hered 61:10-14
39. Wittke-Thompson JK, Pluzhnikov A et al (2005) Rational inferences about deviation from Hardy-Weinberg equilibrium. Am J Hum Genet 76:967-986
40. Luthra K, Tripathi M, Grover R et al (2004) Apolipoprotein E gene polymorphism in Indian patients with Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 17:132-135
41. Thelma BK, Juyal RC, Dodge HH et al (2001) APOE polymorphism in a rural older population-based sample in India. Hum Biol 73:135-144
42. Singh PP, Singh M, Mastana SS (2006) APOE distribution in world populations with new data from India and the UK. Ann Hum Biol 33:279-308